A Digital Intervention to Decrease Self-Stigma Among Pregnant and Postpartum Women With Substance Use Disorder

NARecruitingINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

May 31, 2027

Conditions
Substance Use Disorder
Interventions
BEHAVIORAL

Enhearten with EMI

Enhearten is a digital intervention that is designed to foster adherence to medications for addiction treatment (MAT) and treatment retention while considering the unique needs of pregnant and postpartum women, and recently it has been adapted to include features designed to decrease self-stigma among app-users

BEHAVIORAL

Waitlist Control Group

Participants will receive access to Enhearten with EMI following the trial.

Trial Locations (1)

63110

RECRUITING

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Washington University School of Medicine

OTHER

NCT07211867 - A Digital Intervention to Decrease Self-Stigma Among Pregnant and Postpartum Women With Substance Use Disorder | Biotech Hunter | Biotech Hunter